These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 4148682)

  • 21. Mesalazine foam (Salofalk foam) in the treatment of active distal ulcerative colitis. A comparative trial vs Salofalk enema. The SAF-3 study group.
    Ardizzone S; Doldo P; Ranzi T; Sturniolo GC; Giglio LA; Annese V; D'Arienzo A; Gaia E; Gullini S; Riegler G; Valentini M; Massa P; Del Piano M; Rossini F; Guidetti CS; Pera A; Greinwald R; Bianchi Porro G
    Ital J Gastroenterol Hepatol; 1999 Nov; 31(8):677-84. PubMed ID: 10730559
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The prophylactic effect of salazosulphapyridine in ulcerative colitis during long-term treatment. A double-blind trial on patients asymptomatic for one year.
    Riis P; Anthonisen P; Wulff HR; Folkenborg O; Bonnevie O; Binder V
    Scand J Gastroenterol; 1973; 8(1):71-4. PubMed ID: 4144533
    [No Abstract]   [Full Text] [Related]  

  • 23. [Ulcerative colitis. Maintenance therapy].
    Kruis W; Schreiber S
    Z Gastroenterol; 2004 Sep; 42(9):1011-4. PubMed ID: 15455275
    [No Abstract]   [Full Text] [Related]  

  • 24. A meta-analysis and overview of the literature on treatment options for left-sided ulcerative colitis and ulcerative proctitis.
    Cohen RD; Woseth DM; Thisted RA; Hanauer SB
    Am J Gastroenterol; 2000 May; 95(5):1263-76. PubMed ID: 10811338
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Comparative efficacy of mezakol and sulfasalazine in treating chronic relapsing ulcerative colitis].
    Rogozina VA; Rumiantsev VG
    Eksp Klin Gastroenterol; 2003; (1):58-9, 183. PubMed ID: 12664788
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of Manuka honey and sulfasalazine in combination to promote antioxidant defense system in experimentally induced ulcerative colitis model in rats.
    Medhi B; Prakash A; Avti PK; Saikia UN; Pandhi P; Khanduja KL
    Indian J Exp Biol; 2008 Aug; 46(8):583-90. PubMed ID: 18814487
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mesalamine foam enema versus mesalamine liquid enema in active left-sided ulcerative colitis.
    Cortot A; Maetz D; Degoutte E; Delette O; Meunier P; Tan G; Cazals JB; Dewit O; Hebuterne X; Beorchia S; Grunberg B; Leprince E; D'Haens G; Forestier S; Idier I; Lémann M
    Am J Gastroenterol; 2008 Dec; 103(12):3106-14. PubMed ID: 19086960
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Possible mechanism of action of Azulfidine/Salazopyrin].
    Campbell DE
    Z Gastroenterol Verh; 1981 Jun; 19():15-20. PubMed ID: 6168126
    [No Abstract]   [Full Text] [Related]  

  • 29. Sulphasalazine rectal enemas: topical method of inducing remission of active ulcerative colitis affecting rectum and descending colon.
    Serebro H; Kay S; Javett S; Abrahams C
    Br Med J; 1977 Nov; 2(6097):1264. PubMed ID: 22378
    [No Abstract]   [Full Text] [Related]  

  • 30. [Salozosulphapyridine and its metabolites in ulcerative colitis and Crohn disease].
    Rubinstein BE
    Ugeskr Laeger; 1982 Feb; 144(5):304-6. PubMed ID: 6122297
    [No Abstract]   [Full Text] [Related]  

  • 31. [New salazosulfapyridine derivatives. Progress in the treatment of chronic inflammatory diseases of the intestines?].
    Modigliani R; Rambaud JC
    Gastroenterol Clin Biol; 1987 Apr; 11(4):325-32. PubMed ID: 2884162
    [No Abstract]   [Full Text] [Related]  

  • 32. [Inflammatory diseases of the colon and salazopyrine. Value of long term treatment].
    Chevrel B
    Med Chir Dig; 1976; 5(5):313-7. PubMed ID: 12427
    [No Abstract]   [Full Text] [Related]  

  • 33. Sulphasalazine retention enemas in ulcerative colitis: a double-blind trial.
    Palmer KR; Goepel JR; Holdsworth CD
    Br Med J (Clin Res Ed); 1981 May; 282(6276):1571-3. PubMed ID: 6113021
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Drug management of inflammatory bowel disease.
    McCarthy CF
    Ir Med J; 1983 May; 76(5):260-2. PubMed ID: 6135675
    [No Abstract]   [Full Text] [Related]  

  • 35. The effect of sulphasalazine withdrawal on rectal mucosal function and prostaglandin E2 release in inactive ulcerative colitis.
    Rampton DS; Sladen GE
    Scand J Gastroenterol; 1981; 16(1):157-9. PubMed ID: 6112788
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Sodium cromoglycate in proctitis and ulcerative colitis.
    Allan RN
    Br Med J (Clin Res Ed); 1982 Jan; 284(6309):70-1. PubMed ID: 6119135
    [No Abstract]   [Full Text] [Related]  

  • 37. Paradoxical response to heparin in 10 patients with ulcerative colitis.
    Gaffney PR; Doyle CT; Gaffney A; Hogan J; Hayes DP; Annis P
    Am J Gastroenterol; 1995 Feb; 90(2):220-3. PubMed ID: 7847289
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Studies of intestinal microflora. V. Fecal microbial ecology in ulcerative colitis and regional enteritis: relationship to severity of disease and chemotherapy.
    Gorbach SL; Nahas L; Plaut AG; Weinstein L; Patterson JF; Levitan R
    Gastroenterology; 1968 Apr; 54(4):575-87. PubMed ID: 4385122
    [No Abstract]   [Full Text] [Related]  

  • 39. A double-blind comparison of oral versus rectal mesalamine versus combination therapy in the treatment of distal ulcerative colitis.
    Safdi M; DeMicco M; Sninsky C; Banks P; Wruble L; Deren J; Koval G; Nichols T; Targan S; Fleishman C; Wiita B
    Am J Gastroenterol; 1997 Oct; 92(10):1867-71. PubMed ID: 9382054
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Current concepts on the pharmacokinetics of salazopyrine and new therapeutic trends in ulcerohemorrhagic rectocolitis].
    Gheorghescu B
    Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Med Interna; 1981; 33(5):339-44. PubMed ID: 6122244
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.